GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
SpaceX IPO: Is This the 10X Stock You've Been Waiting For?
The SpaceX IPO should be one of the biggest in history.
NVDA
Oklo Links Nuclear Reactors To AI Growth With NVIDIA And LANL Partnership
Oklo (NYSE:OKLO) has entered into a partnership with NVIDIA and Los Alamos National Laboratory to support nuclear powered AI infrastructure and plutonium fuel research. The collaboration aims to combine Oklo's advanced reactor work with NVIDIA's AI systems and LANL's nuclear research capabilities to support energy hungry data centers and nuclear R&D. The news highlights Oklo's effort to link its reactor projects to the growing demand from AI and advanced computing sectors. For investors...
PLTR
A Look At Palantir Technologies (PLTR) Valuation After Recent Share Price Volatility
Palantir’s recent performance and what it might mean for investors Palantir Technologies (PLTR) has drawn investor attention after a mixed stretch in the stock, with a 1 day gain of 3.6% but negative returns over the past month and past 3 months. See our latest analysis for Palantir Technologies. That 3.6% 1 day share price gain to around $144 comes after a weaker stretch, with a 30 day share price return of roughly 3% and a year to date share price decline of about 14%. At the same time, the...
MRNA
Moderna (MRNA) Is Down 10.6% After Q1 Loss Widened On Settlement And EU Vaccine Wins – Has The Bull Case Changed?
In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, while net loss widened to US$1.34 billion, largely reflecting a US$950 million litigation settlement, and the company also secured European approvals for several vaccines including mCOMBRIAX, the first flu and COVID-19 combination shot. Beyond the headline loss, the quarter highlighted Moderna’s growing reliance on international government partnerships, especially the U.K. deal, and...
VRTX
How Investors Are Reacting To Vertex (VRTX) FDA ALYFTREK Expansion and Evolving Pipeline Story
Recently, Vertex Pharmaceuticals reported that director Suketu Upadhyay will leave its board at the 2026 annual meeting while the US FDA approved expanded use of ALYFTREK for cystic fibrosis patients aged 6 and older. At the same time, Bank of America reaffirmed Vertex as a top large-cap biotech pick, underscoring how its cystic fibrosis cash flows are supporting a broader pipeline that now includes a rare kidney disease franchise. We’ll now examine how the FDA’s expanded ALYFTREK approval...
HD
The Bull Case For Home Depot (HD) Could Change Following Wren Kitchens’ Abrupt Bankruptcy Fallout
In early May 2026, Home Depot was hit by the abrupt Chapter 7 bankruptcy of partner Wren Kitchens, which suddenly shut its U.S. operations and left customers facing stalled deliveries, refund challenges, and state investigations while Home Depot assessed how to respond. This disruption highlights how reliance on third‑party installers and in‑store studio partners can create operational and reputational risks that extend well beyond product sales. We’ll now explore how the Wren Kitchens...
TWLO
TWLO Q1 Deep Dive: AI-Driven Channel Expansion Fuels Growth and Margin Gains
Customer engagement platform Twilio (NYSE:TWLO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 20% year on year to $1.41 billion. Guidance for next quarter’s revenue was optimistic at $1.43 billion at the midpoint, 2.6% above analysts’ estimates. Its non-GAAP profit of $1.50 per share was 18% above analysts’ consensus estimates.
NKE
Why Nike Stock Lost 16% in April
The stock tumbled on earnings and never recovered.
INTC
Why Nike Stock Lost 16% in April
The stock tumbled on earnings and never recovered.
NVDA
Why Nike Stock Lost 16% in April
The stock tumbled on earnings and never recovered.
UNH
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
REGN
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.